Jon Chung - Concepedia

Author

Jon Chung

Foundation Medicine (United States)ORCID

Also Known As

Alexa Schrock, J Chung, J. Chung, J. H. Chung, J.H. Chung, Jesseca M. Chung, Jon Chung, Jon H Chung, Jon H. Chung

286

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Foundation Medicine (United States)SUNY Upstate Medical University Fondazione IRCCS Istituto Nazionale dei Tumori Albany Medical Center Hospital Dana-Farber Cancer Institute

About

Jon Chung is an author at Foundation Medicine (United States) specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	28	1.6K
2	Health Sciences	3	3	78
3	Engineering	1	1	99
4	Natural Sciences	1	1	72
5	Biology	1	1	72

Jon Chung

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study Andrea Necchi, Andrea Anichini, Daniele Raggi, Journal of Clinical Oncology	2018	712
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers Aatur D. Singhi, Ben George, Joel Greenbowe, Gastroenterology	2019	329
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies Andrea Necchi, Daniele Raggi, Andrea Gallina, European Urology UrologyGenitourinary CancerMuscle-invasive Bladder CarcinomaMedicinePathology	2019	313
Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA Travis Clark, Jon Chung, Mark Kennedy, Journal of Molecular Diagnostics	2018	191
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms Hanna Tukachinsky, Russell W. Madison, Jon Chung, Clinical Cancer Research	2021	186
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer Pingping Mao, Ofir Cohen, Kailey J. Kowalski, Clinical Cancer Research	2020	178
Pan-Cancer Analysis of <i>BRCA1</i> and <i>BRCA2</i> Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity Ethan S. Sokol, Dean C. Pavlick, Hossein Khiabanian, JCO Precision Oncology	2020	172
Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors Jon Chung, Ninad Dewal, Ethan Sokol, JCO Precision Oncology	2019	160
RET rearrangements are actionable alterations in breast cancer Bhavna Paratala, Jon Chung, Casey Williams, Nature Communications Ret AmplificationRet RearrangementsBreast OncologyOncogenic Gene RetMedicine	2018	123
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling Sumanta K. Pal, Siraj M. Ali, Evgeny Yakirevich, European Urology UrologyGenitourinary CancerTumor HeterogeneityComprehensive Genomic ProfilingMedicine	2017	111

Page 1